Fidelity European Trust outperforms as financial, health care and cosmetic stocks rise

Fidelity

Fidelity European Trust PLC (LON:FEV) monthly factsheet for the period ended 31 March 2023.

Portfolio Manager Commentary

Continental European equities delivered a small positive return over March, despite significant volatility due to the collapse of Silicon Valley and Signature Banks in the US and subsequent failure of Credit Suisse in Europe, which led to fears of wider contagion in the banking sector. Despite the market volatility, the European Central Bank (ECB) raised rates by 0.5% as expected in March. The central bank reassured markets that it is “fully equipped” to provide additional support to the banking system to preserve financial stability. ECB President Christine Lagarde continued to signal that further rate hikes would be based on data releases and observed that “inflation is projected to remain too high for too long”. That
said, headline inflation in the eurozone fell to 6.9% in March from 8.5% in February.

During the month, the Trust recorded positive returns and outperformed the index. The outperformance was driven by the overweight in consumer discretionary and technology, and strong stock picking in financials. At a stock level, cosmetics major L’Oreal was the biggest contributor as shares advanced on broker upgrades. Health care companies Novo Nordisk and Sanofi were also among the strong performers.

On a rolling 12-month basis, the Trust recorded NAV and share price returns of 12.6% and 14.1% respectively, compared to 8.7% for the index.

Fidelity European Trust PLC (LON:FEV) is a European investment trust. It  aims to be the cornerstone long-term investment of choice for those seeking European exposure across market cycles.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Fidelity European Trust plc posts 21% annual share price gain amid European rally

European equities finished 2025 close to record levels, supported by strong earnings, easing financial conditions, and improving policy momentum.

European stocks rise as geopolitical risk recedes

European stocks gained as trade tensions eased and tech sentiment lifted investor appetite across the region.

Strategic shifts and utility gains steady European markets

European markets continue to evolve in response to complex global drivers that influence risk appetite and corporate performance.

Capture growth investment opportunities in Europe in 2026

Portfolio managers Sam Morse and Marcel Stötzel outline why they continue to see opportunity in Europe in 2026.

European stocks climb as defence takes centre stage in investor positioning

European stocks climb as investors rotate into defence, responding decisively to rising geopolitical risk.

European Investment Trust performance boosted by Roche drug trial success (LON: FEV)

Continental European markets delivered positive returns in November. Fidelity European Trust saw encouraging contributions from Roche and ABN AMRO and remains positioned for long-term growth through disciplined stock selection and a focus on sustainable cash flows.

Search

Search